The Therapeutic Sciences Graduate Program (TSGP) houses two degree programs: a PhD in Therapeutic Sciences, described here; and a Master's degree in Biotechnology described at a separate website (Biotechnology Master's Program). TSGP also includes MD/PhD students and 5th-year masters students from Brown. Shared activities and courses promote a sense of community within all of TSGP.
The Therapeutic Sciences PhD program covers pharmacology, physiology, and biotechnology, as well as other fields that are part of the broader area of therapeutic sciences. For example, the program includes studies of drug targets in the immune system that are important in treating infectious diseases, characterization of brain mechanisms of addiction with an eye toward therapy, approaches to understanding and treating cancer, and applications of cell and tissue-based therapies. Thus, TSGP offers advanced training appropriate for academic and research careers in the fields of biology and medical sciences with a focus on determining disease mechanisms and drug actions, and developing novel therapies. The PhD program is funded in part by an NIH training grant (T32) through the NIGMS Program in Pharmacological Sciences.
TSGP at Brown has a very accomplished history and a reputation for being an intimate, very diverse and inclusive program with outstanding student outcomes. To get a feel for the collaborative atmosphere in TSGP, please watch our video below.
Admission is ordinarily limited to applicants for the PhD. Admission for internal 5th year masters degrees is permitted, but only for Brown undergraduate students, and with preference given to those students already working in a research lab at Brown.
The program also admits Brown MD/PhD students, and they typically receive course credit for their medical courses.